143 related articles for article (PubMed ID: 27022932)
21. Absence of symptom and intact liver function are positive prognosticators for patients undergoing radiotherapy for lymph node metastasis from hepatocellular carcinoma.
Kim K; Chie EK; Kim W; Kim YJ; Yoon JH; Lee HS; Ha SW
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):729-34. PubMed ID: 20171806
[TBL] [Abstract][Full Text] [Related]
22. Adverse hepatic events caused by radiotherapy for advanced hepatocellular carcinoma.
Furuse J; Ishii H; Nagase M; Kawashima M; Ogino T; Yoshino M
J Gastroenterol Hepatol; 2005 Oct; 20(10):1512-8. PubMed ID: 16174067
[TBL] [Abstract][Full Text] [Related]
23. Prognostic stratification and nomogram for survival prediction in hepatocellular carcinoma patients treated with radiotherapy for lymph node metastasis.
Wee CW; Kim K; Chie EK; Yu SJ; Kim YJ; Yoon JH
Br J Radiol; 2016 Sep; 89(1065):20160383. PubMed ID: 27416997
[TBL] [Abstract][Full Text] [Related]
24. Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity.
Padia SA; Kwan SW; Roudsari B; Monsky WL; Coveler A; Harris WP
J Vasc Interv Radiol; 2014 Jul; 25(7):1067-73. PubMed ID: 24837982
[TBL] [Abstract][Full Text] [Related]
25. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
26. A single center experience of sorafenib in advanced hepatocellular carcinoma patients: evaluation of prognostic factors.
Song T; Zhang W; Wu Q; Kong D; Ma W
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1233-8. PubMed ID: 21941188
[TBL] [Abstract][Full Text] [Related]
27. Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis.
Kokabi N; Camacho JC; Xing M; El-Rayes BF; Spivey JR; Knechtle SJ; Kim HS
Cancer; 2015 Jul; 121(13):2164-74. PubMed ID: 25847227
[TBL] [Abstract][Full Text] [Related]
28. Defining prognostic factors of survival after external beam radiotherapy treatment of hepatocellular carcinoma with lymph node metastases.
Chen YX; Zeng ZC; Fan J; Tang ZY; Zhou J; Zeng MS; Zhang JY; Sun J
Clin Transl Oncol; 2013 Sep; 15(9):732-40. PubMed ID: 23381897
[TBL] [Abstract][Full Text] [Related]
29. The efficacy of high-dose 3-dimensional conformal radiation therapy in patients with small hepatocellular carcinoma not eligible for other local modalities.
Lim DH; Lee H; Park HC; Lee JA; Kim SW; Yoo BC; Koh KC; Lee JH; Choi MS; Gwak GY; Paik SW
Am J Clin Oncol; 2013 Apr; 36(2):162-6. PubMed ID: 22391433
[TBL] [Abstract][Full Text] [Related]
30. Stereotactic ablative radiotherapy for pulmonary oligometastases from primary hepatocellular carcinoma: a multicenter and retrospective analysis (KROG 17-08).
Jo IY; Park HC; Kim ES; Yeo SG; Kim M; Seong J; Kim JW; Kim TH; Yoon WS; Jeong BK; Kim SH; Lee JH
Jpn J Clin Oncol; 2022 May; 52(6):616-622. PubMed ID: 35311896
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of transarterial chemoembolization plus sorafenib for hepatocellular carcinoma with portal venous tumour thrombus.
Pan T; Li XS; Xie QK; Wang JP; Li W; Wu PH; Zhao M
Clin Radiol; 2014 Dec; 69(12):e553-61. PubMed ID: 25304928
[TBL] [Abstract][Full Text] [Related]
32. Improved oncologic outcomes by ablative radiotherapy in patients with bone metastasis from hepatocellular carcinoma.
Kim TH; Park S; Rim CH; Choi C; Seong J
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2693-2700. PubMed ID: 33582874
[TBL] [Abstract][Full Text] [Related]
33. The role of radiotherapy in the treatment of hepatocellular carcinoma with portal vein tumor thrombus.
Yeh SA; Chen YS; Perng DS
J Radiat Res; 2015 Mar; 56(2):325-31. PubMed ID: 25411553
[TBL] [Abstract][Full Text] [Related]
34. Multimodality treatment with radiotherapy for huge hepatocellular carcinoma.
Han HJ; Kim MS; Cha J; Choi JS; Han KH; Seong J
Oncology; 2014; 87 Suppl 1():82-9. PubMed ID: 25427738
[TBL] [Abstract][Full Text] [Related]
35. A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus.
Zeng ZC; Fan J; Tang ZY; Zhou J; Qin LX; Wang JH; Sun HC; Wang BL; Zhang JY; Jiang GL; Wang YQ
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):432-43. PubMed ID: 15667964
[TBL] [Abstract][Full Text] [Related]
36. Effects of Atezolizumab and Bevacizumab on Adrenal Gland Metastasis of Hepatocellular Carcinoma: A Case Report and Review of Literature.
Ishikawa N; Kamimura K; Endo S; Ishii S; Ogawa K; Sakai N; Abe H; Ko M; Shibata O; Koseki Y; Yokoyama J; Sakamaki A; Terai S
Intern Med; 2022 Nov; 61(21):3233-3237. PubMed ID: 35431306
[TBL] [Abstract][Full Text] [Related]
37. Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma.
Kawaoka T; Aikata H; Hyogo H; Morio R; Morio K; Hatooka M; Fukuhara T; Kobayashi T; Naeshiro N; Miyaki D; Hiramatsu A; Imamura M; Kawakami Y; Takahashi S; Waki K; Tsuji K; Kohno H; Kohno H; Moriya T; Chayama K
J Dig Dis; 2015 Sep; 16(9):505-12. PubMed ID: 26121102
[TBL] [Abstract][Full Text] [Related]
38. Prognostic efficacy of treatment for extrahepatic metastasis after surgical treatment of hepatocellular carcinoma.
Imamura I
Kurume Med J; 2003; 50(1-2):41-8. PubMed ID: 12971262
[TBL] [Abstract][Full Text] [Related]
39. Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors.
Kanda M; Tateishi R; Yoshida H; Sato T; Masuzaki R; Ohki T; Imamura J; Goto T; Yoshida H; Hamamura K; Obi S; Kanai F; Shiina S; Omata M
Liver Int; 2008 Nov; 28(9):1256-63. PubMed ID: 18710423
[TBL] [Abstract][Full Text] [Related]
40. Radiotherapy for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels: efficacy and outcomes.
Tanaka Y; Nakazawa T; Komori S; Hidaka H; Okuwaki Y; Takada J; Watanabe M; Shibuya A; Minamino T; Yamamoto H; Kokubu S; Hayakawa K; Koizumi W
J Gastroenterol Hepatol; 2014 Feb; 29(2):352-7. PubMed ID: 23869689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
